ABVC: ABVC BioPharma, Inc. Stock

by  •  • Comments Off on ABVC: ABVC BioPharma, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 16.16
Enterprise Value ($M) 17.88
Book Value ($M) 7.98
Book Value / Share 0.65
Price / Book 2.03
NCAV ($M) -4.34
NCAV / Share -0.35
Price / NCAV -3.73

Profitability (mra)
Return on Invested Capital (ROIC) -0.77
Return on Assets (ROA) -0.57
Return on Equity (ROE) -1.10

Liquidity (mrq)
Quick Ratio 0.34
Current Ratio 0.34

Balance Sheet (mrq) ($M)
Current Assets 2.15
Assets 14.46
Liabilities 6.48
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Lind Global Fund II LP 9.90 15.22

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO S
2024-05-17 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-02 140,615 648,519 21.68
2025-04-01 694,266 1,980,896 35.05
2025-03-31 253,221 816,325 31.02
2025-03-28 74,555 214,227 34.80

(click for more detail)

Similar Companies
ABEO – Abeona Therapeutics Inc. ACB – Aurora Cannabis Inc.
ACHV – Achieve Life Sciences, Inc.


Financial data and stock pages provided by
Fintel.io